Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

C-terminal truncations in IQSEC2: implications for synaptic localization, guanine nucleotide exchange factor activity, and neurological manifestations

Abstract

IQSEC2 gene on chromosome Xq11.22 encodes a member of guanine nucleotide exchange factor (GEF) protein that is implicated in the activation of ADP-ribosylation factors (Arfs) at the postsynaptic density (PSD), and plays a crucial role in synaptic transmission and dendritic spine formation. Alterations in IQSEC2 have been linked to X-linked intellectual developmental disorders including epilepsy and behavioral abnormalities. Of interest, truncating variants at the C-terminus of IQSEC2 can cause severe phenotypes, akin to truncating variants located in other regions. Here, we present a 5-year-old boy with severe intellectual disability and progressive epilepsy. The individual carried a nonsense variant p.Q1227* in the last exon of the IQSEC2 gene that was supposed to escape nonsense-mediated mRNA decay, thereby leading to a translation of C-terminus truncated IQSEC2 protein with residual activity. The functional analyses showed that the GEF activity of IQSEC2 Q1227* was compromised, and that the IQSEC2 Q1227* lacked preferential synaptic localization due to the absence of functional domains for binding to scaffolding proteins in the PSD. The impaired GEF activity and disrupted synaptic localization of the mutant IQSEC2 protein could impact dendritic and spine development in neurons, potentially explaining the patient’s severe neurological manifestations. Our findings indicate that C-terminal truncations in IQSEC2, previously not well-characterized, may have significant pathogenic implications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Murphy JA, Jensen ON, Walikonis RS. BRAG1, a Sec7 domain-containing protein, is a component of the postsynaptic density of excitatory synapses. Brain Res. 2006;1120:35–45.

    Article  CAS  PubMed  Google Scholar 

  2. Sakagami H, Sanda M, Fukaya M, Miyazaki T, Sukegawa J, Yanagisawa T, et al. IQ-ArfGEF/BRAG1 is a guanine nucleotide exchange factor for Arf6 that interacts with PSD-95 at postsynaptic density of excitatory synapses. Neurosci Res. 2008;60:199–212.

    Article  CAS  PubMed  Google Scholar 

  3. Sanda M, Kamata A, Katsumata O, Fukunaga K, Watanabe M, Kondo H, et al. The postsynaptic density protein, IQ-ArfGEF/BRAG1, can interact with IRSp53 through its proline-rich sequence. Brain Res. 2009;1251:7–15.

    Article  CAS  PubMed  Google Scholar 

  4. Brown JC, Petersen A, Zhong L, Himelright ML, Murphy JA, Walikonis RS, et al. Bidirectional regulation of synaptic transmission by BRAG1/IQSEC2 and its requirement in long-term depression. Nat Commun. 2016;7:11080.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hinze SJ, Jackson MR, Lie S, Jolly L, Field M, Barry SC, et al. Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis. Transl Psychiatry. 2017;7:e1110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Shoubridge C, Tarpey PS, Abidi F, Ramsden SL, Rujirabanjerd S, Murphy JA, et al. Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability. Nat Genet. 2010;42:486–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mignot C, McMahon AC, Bar C, Campeau PM, Davidson C, Buratti J, et al. IQSEC2-related encephalopathy in males and females: a comparative study including 37 novel patients. Genet Med. 2019;21:837–49.

    Article  CAS  PubMed  Google Scholar 

  8. Shoubridge C, Harvey RJ, Dudding-Byth T. IQSEC2 mutation update and review of the female-specific phenotype spectrum including intellectual disability and epilepsy. Hum Mutat. 2019;40:5–24.

    Article  CAS  PubMed  Google Scholar 

  9. Tejada MI, Ibarluzea N. Non-syndromic X linked intellectual disability: Current knowledge in light of the recent advances in molecular and functional studies. Clin Genet. 2020;97:677–87.

    Article  CAS  PubMed  Google Scholar 

  10. Lopergolo D, Privitera F, Castello G, Lo Rizzo C, Mencarelli MA, Pinto AM, et al. IQSEC2 disorder: A new disease entity or a Rett spectrum continuum? Clin Genet. 2021;99:462–74.

    Article  CAS  PubMed  Google Scholar 

  11. Yamazawa K, Inoue T, Sakemi Y, Nakashima T, Yamashita H, Khono K, et al. Loss of imprinting of the human-specific imprinted gene ZNF597 causes prenatal growth retardation and dysmorphic features: implications for phenotypic overlap with Silver-Russell syndrome. J Med Genet. 2021;58:427–32.

    Article  PubMed  Google Scholar 

  12. Takatsu H, Yoshino K, Toda K, Nakayama K. GGA proteins associate with Golgi membranes through interaction between their GGAH domains and ADP-ribosylation factors. Biochem J. 2002;365:369–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hara Y, Fukaya M, Hayashi K, Kawauchi T, Nakajima K, and Sakagami H. ADP Ribosylation Factor 6 regulates neuronal migration in the developing cerebral cortex through FIP3/Arfophilin-1-dependent Endosomal Trafficking of N-cadherin. eNeuro. 2016;3:ENEURO.0148–16.2016.

  14. Fukaya M, Sugawara T, Hara Y, Itakura M, Watanabe M, Sakagami H. BRAG2a mediates mGluR-dependent AMPA receptor internalization at excitatory postsynapses through the interaction with PSD-95 and Endophilin 3. J Neurosci. 2020;40:4277–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Radley JA, O’Sullivan RBG, Turton SE, Cox H, Vogt J, Morton J, et al. Deep phenotyping of 14 new patients with IQSEC2 variants, including monozygotic twins of discordant phenotype. Clin Genet. 2019;95:496–506.

    Article  CAS  PubMed  Google Scholar 

  16. Levy NS, Borisov V, Lache O, and Levy AP Molecular Insights into IQSEC2 Disease. Int J Mol Sci. 2023;24:4984.

  17. Barrie ES, Cottrell CE, Gastier-Foster J, Hickey SE, Patel AD, Santoro SL, et al. Genotype-phenotype correlation: Inheritance and variant-type infer pathogenicity in IQSEC2 gene. Eur J Med Genet. 2020;63:103735.

    Article  PubMed  Google Scholar 

  18. Renieri A, Mari F, Mencarelli MA, Scala E, Ariani F, Longo I, et al. Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant). Brain Dev. 2009;31:208–16.

    Article  CAS  PubMed  Google Scholar 

  19. Mitter D, Pringsheim M, Kaulisch M, Plumacher KS, Schroder S, Warthemann R, et al. FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants. Genet Med. 2018;20:98–108.

    Article  CAS  PubMed  Google Scholar 

  20. Choi J, Ko J, Racz B, Burette A, Lee JR, Kim S, et al. Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases. J Neurosci. 2005;25:869–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hernandez-Deviez DJ, Casanova JE, Wilson JM. Regulation of dendritic development by the ARF exchange factor ARNO. Nat Neurosci. 2002;5:623–4.

    Article  CAS  PubMed  Google Scholar 

  22. Choi S, Ko J, Lee JR, Lee HW, Kim K, Chung HS, et al. ARF6 and EFA6A regulate the development and maintenance of dendritic spines. J Neurosci. 2006;26:4811–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the patient and parents for their cooperation. This work was supported in part by JSPS KAKENHI (Grant numbers: 19H03628, 21K19751, 22H03048, and 23K06322).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Hiroyuki Sakagami or Kazuki Yamazawa.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakashima, M., Shiroshima, T., Fukaya, M. et al. C-terminal truncations in IQSEC2: implications for synaptic localization, guanine nucleotide exchange factor activity, and neurological manifestations. J Hum Genet 69, 119–123 (2024). https://doi.org/10.1038/s10038-023-01210-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-023-01210-9

Search

Quick links